pArtiaL zonA pelluciDa Removal by assisteD hatchINg of Blastocysts
Does Partial Zona Pellucida Removal From Vitrified-warmed Human Blastocysts Improve Delivery Rate in IVF? A Multicentric RCT on Laser Assisted Hatching
1 other identifier
interventional
700
1 country
2
Brief Summary
The aim of study is to assess the possible impact of assisted hatching on delivery rate after transfer of vitrified-warmed human blastocysts.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2018
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 3, 2018
CompletedFirst Posted
Study publicly available on registry
August 9, 2018
CompletedStudy Start
First participant enrolled
September 5, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 20, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 20, 2023
CompletedJanuary 23, 2023
January 1, 2023
4.4 years
August 3, 2018
January 20, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Delivery rate
Number of deliveries, that result in a live birth, per transferred blastocyst
38 weeks after embryo transfer
Secondary Outcomes (7)
Implantation rate
6-7 weeks after transfer
Clinical Pregnancy rate
4 weeks after transfer
Biochemical pregnancy rate
4 week after transfer
Ongoing pregnancy rate
20 weeks after transfer
Multiple pregnancy rate
4 week after transfer
- +2 more secondary outcomes
Study Arms (2)
AH group
ACTIVE COMPARATORSubjects whose vitrified/warmed blastocysts will be subjected to the treatment of laser assisted hatching
Control group
NO INTERVENTIONSubjects whose vitrified/warmed blastocysts will be subjected to the same procedures except for the treatment of laser assisted hatching
Interventions
After warming, blastocysts are subjected to laser assisted hatching (LAH) following the standard procedure.The LAH procedure lasts one minute per blastocyst.
Eligibility Criteria
You may qualify if:
- single embryo transfer of vitrified/warmed blastocyst (SET)
- first or second frozen IVF (with or without Intracytoplasmic Sperm Injection) cycle of blastocysts
- first or second oocyte retrieval
You may not qualify if:
- Preimplantation Genetic Testing (PGT) cycle
- BMI \> 35 kg/m2
- severe male factor
- abnormal uterine cavity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Milan, 20122, Italy
IRCCS San Raffaele
Milan, 20132, Italy
Related Publications (3)
Alteri A, Vigano P, Maizar AA, Jovine L, Giacomini E, Rubino P. Revisiting embryo assisted hatching approaches: a systematic review of the current protocols. J Assist Reprod Genet. 2018 Mar;35(3):367-391. doi: 10.1007/s10815-018-1118-4. Epub 2018 Jan 19.
PMID: 29350315BACKGROUNDAlteri A, Reschini M, Guarneri C, Bandini V, Bertapelle G, Pinna M, Rabellotti E, Ferrari S, Papaleo E, Paffoni A, Vigano P, Somigliana E. The effect of laser-assisted hatching on vitrified/warmed blastocysts: the ALADDIN randomized controlled trial. Fertil Steril. 2024 Jul;122(1):106-113. doi: 10.1016/j.fertnstert.2024.02.010. Epub 2024 Feb 9.
PMID: 38342371DERIVEDAlteri A, Guarneri C, Corti L, Restelli L, Reschini M, Giardina P, Papaleo E, Somigliana E, Vigano P, Paffoni A. ALADDIN study: does assisted hatching of vitrified/warmed blastocysts improve live birth rate? Protocol for a multicentric randomised controlled trial. BMJ Open. 2020 Jul 19;10(7):e031544. doi: 10.1136/bmjopen-2019-031544.
PMID: 32690492DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alessandra Alteri, PhD
IRCCS San Raffaele
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, PhD
Study Record Dates
First Submitted
August 3, 2018
First Posted
August 9, 2018
Study Start
September 5, 2018
Primary Completion
January 20, 2023
Study Completion
January 20, 2023
Last Updated
January 23, 2023
Record last verified: 2023-01